Aortic endovascular repair

Strength in evidence.

The proof is in the results.

Alert Indications, Safety, and Warnings

You’re invested in durable outcomes for your patients. So are we. Medtronic maintains the longest-term aortic clinical evidence in the industry. We are invested in building the strength of aortic evidence that answers key clinical questions and elevates the standard of care.

Invested in building long-term clinical evidence

Medtronic maintains the longest-term clinical evidence in the industry, consistently showing successful clinical outcomes across different patient anatomies and the entire aortic portfolio.

  • Unparalleled rigorous data collection process
  • Medtronic ENGAGE OUS global patient registry with over 1,200 real-world participants and longest published evidence
  • 400+ peer-reviewed publications on the Valiant™ Captivia™ thoracic stent graft system
  • Demonstrated outcomes through five years in all DTA pathologies
  • ANCHOR Registry five-year results on the Heli-FX™ EndoAnchor™ system

We are continuing to build our body of evidence by investing in randomized controlled trials (RCTs).

Endurant AAA stent graft system — the standard of EVAR durability with 10-year data

As the first and only EVAR (endovascular aortic repair) system with a decade of global registry outcomes, Endurant systems continue to prove durability and strength in evidence with consistently high sac regression and low aneurysm-related mortality (ARM).1

Choose the standard of EVAR durability.

See Endurant II/IIs outcomes
Endurant IIs stent graft on white background encircled by blue dots

Risks associated with EVAR procedures may include rupture, conversion to open repair, or secondary procedures.

Valiant thoracic stent graft with the Captivia delivery system encircled by blue dots

Valiant Captivia thoracic stent graft system five-year outcomes in all DTA pathologies

Valiant Captivia system provides consistent clinical performance across a variety of pathologies and five-year outcomes in all descending thoracic aortic (DTA) pathologies.

See Valiant Captivia outcomes

Risks associated with TEVAR procedures may include rupture, conversion to open repair, or secondary procedures.

Proven durability with ESAR

EndoSuture aneurysm repair (ESAR) with the Heli-FX EndoAnchor system continues to demonstrate durable results in challenging patient with low type Ia endoleaks, low reinterventions, and positive sac regression rates.2

See Heli-FX outcomes
Heli-FX EndoAnchor implant on transparent background with blue dotted border

Risks may include failure to prevent/correct type I endoleaks, migration, or sac enlargement.

Related products and procedures

Medtronic Academy

Access interactive courses, case studies, presentations, and videos from your phone, tablet, or desktop.

Sign in

Stay connected.

Sign up for upcoming aortic events, training opportunities, and updates.

Sign up

References

1

Verhagen H, et al. The ENGAGE Registry: Ten-Year Outcomes with the Endurant Stent Graft for Endovascular Abdominal Aortic Aneurysm Repair. Presented at: Charing Cross 2023 International Symposium; April 26, 2023; London, UK.

2

Jordan WD, Jr. New Developments from the ANCHOR Registry: Early 5 Year Prophylactic Results. Presented at VEITH Symposium 2021; Orlando, Florida.